Contaminated HGH Treatment Linked to Early Alzheimers in Some Patients: Report

New Study Finds Possible Link Between Human Growth Hormone and Early Onset Alzheimer’s

A groundbreaking study published in the journal Nature Medicine has shed light on a potential connection between human growth hormone (HGH) and the development of early cases of Alzheimer’s disease. The study examined patients who received HGH treatments from 1959 to 1985, which were sourced from the pituitary glands of cadaver donors.

During this period, some patients who received HGH displayed symptoms of early onset Alzheimer’s disease, with the youngest patient being only 38 years old. Researchers conducting the study discovered that the HGH samples used during this time may have been contaminated with a protein associated with Alzheimer’s disease.

It is important to note, however, that the study’s authors caution against overextending the scope of the results. They emphasize that Alzheimer’s is not a transmissible disease like a viral or bacterial infection. The observed link does not imply that Alzheimer’s can be transmitted through HGH treatments or any other means.

The procedure that led to these patients developing Alzheimer’s has been discontinued for several decades. Measures have since been put in place to ensure the safety and purity of HGH treatments. The medical community has learned from this unfortunate episode and taken steps to prevent similar occurrences in the future.

While this study sheds some light on the potential risks associated with HGH treatments in the past, it is crucial to recognize that advancements in medical research and practices have greatly improved the safety and efficacy of these treatments. Patients today can have confidence in the stringent measures that are in place to ensure their well-being.

See also  COVID-19 Cases and Hospitalizations Rising in Wisconsin, According to DHS Reports - Bio Prep Watch

Alzheimer’s disease remains a complex condition with a multitude of factors influencing its onset and progression. Further research is needed to fully understand the relationship between HGH and Alzheimer’s and to explore additional risk factors that may contribute to the development of this devastating disease.

As we await further scientific insights, it is essential to stay informed and continue supporting research efforts to discover effective treatments and preventive measures for Alzheimer’s disease. The findings from this study contribute to our understanding of the disease and ultimately bring us one step closer to combating it.

LEAVE A REPLY

Please enter your comment!
Please enter your name here